购物车
全部删除
您的购物车当前为空
NMS-P515 is an effective, orally active, and stereospecific PARP-1 inhibitor (Kd: 16 nM and an IC50: 27 nM (in Hela cells)). It has anti-tumor activity.

NMS-P515 is an effective, orally active, and stereospecific PARP-1 inhibitor (Kd: 16 nM and an IC50: 27 nM (in Hela cells)). It has anti-tumor activity.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 2 mg | ¥ 3,420 | 5日内发货 | |
| 25 mg | ¥ 12,800 | 8-10周 | |
| 50 mg | ¥ 16,800 | 8-10周 | |
| 100 mg | ¥ 21,500 | 8-10周 |
| 产品描述 | NMS-P515 is an effective, orally active, and stereospecific PARP-1 inhibitor (Kd: 16 nM and an IC50: 27 nM (in Hela cells)). It has anti-tumor activity. |
| 靶点活性 | PARP1:27 nM (in Hela cells), PARP1:16 nM (kd) |
| 体内活性 | NMS-P515 (80 mg/kg; p.o.; 12 days) shows effective antitumor activity in mouse models based on pancreatic cancer. |
| 分子量 | 355.47 |
| 分子式 | C21H29N3O2 |
| CAS No. | 1262395-13-0 |
| 密度 | 1.200 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
对于不同动物的给药剂量换算,您也可以参考 更多